Guanfacine 1 mg/1 (Guanfacine TABLET, EXTENDED RELEASE) 1 mg/1

Guanfacine 1 mg extended-release tablets are used to manage certain conditions like high blood pressure and ADHD. This medication helps regulate blood pressure and improve focus.

Strength

1 mg/1

Pack Size

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2850-11)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Guanfacine is primarily used for managing high blood pressure and attention deficit hyperactivity disorder (ADHD). It works by affecting certain receptors in the brain to help regulate blood pressure and improve concentration. People often ask, 'What is guanfacine used for?' and the answer includes its role in treating these conditions.

Side Effects

Common effects of guanfacine may include drowsiness, dry mouth, and dizziness. Some users also report mild headaches or fatigue. These effects can vary depending on individual tolerance and dosage.

Precautions & Warnings

Guanfacine should be handled with care, especially by individuals with certain medical conditions like heart problems or low blood pressure. It is important to follow the advice of a healthcare provider regarding its use. Always store guanfacine in a cool, dry place away from children.

Avoid Interactions

Guanfacine may interact with other medications, including those used for high blood pressure, depression, and certain pain relievers. It is also advisable to avoid alcohol while taking guanfacine, as it can enhance sedative effects. Always consult a healthcare provider before combining guanfacine with other treatments.

Frequently Asked Questions

Guanfacine is used to manage high blood pressure and attention deficit hyperactivity disorder (ADHD).

Guanfacine is typically taken orally, usually once a day. It is important to follow the instructions provided by a healthcare professional.

Common side effects include drowsiness, dry mouth, dizziness, and mild headaches.

Guanfacine may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Guanfacine should be used with caution by individuals with certain medical conditions, such as heart problems or low blood pressure.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.